Correlation Between Immutep and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Immutep and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Immutep and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and NLS Pharmaceutics.
Diversification Opportunities for Immutep and NLS Pharmaceutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Immutep and NLS is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Immutep i.e., Immutep and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Immutep and NLS Pharmaceutics
Given the investment horizon of 90 days Immutep Ltd ADR is expected to generate 0.58 times more return on investment than NLS Pharmaceutics. However, Immutep Ltd ADR is 1.74 times less risky than NLS Pharmaceutics. It trades about 0.03 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.04 per unit of risk. If you would invest 160.00 in Immutep Ltd ADR on August 29, 2024 and sell it today you would earn a total of 31.00 from holding Immutep Ltd ADR or generate 19.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.49% |
| Values | Daily Returns |
Immutep Ltd ADR vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Immutep Ltd ADR |
| NLS Pharmaceutics |
Immutep and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immutep and NLS Pharmaceutics
The main advantage of trading using opposite Immutep and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
| NLS Pharmaceutics vs. Eliem Therapeutics | NLS Pharmaceutics vs. Scpharmaceuticals | NLS Pharmaceutics vs. Milestone Pharmaceuticals | NLS Pharmaceutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |